Skip to content
The Policy VaultThe Policy Vault

voriconazoleMedica

Aspergillus infection – treatment

Initial criteria

  • Approve for the indication(s) listed

Reauthorization criteria

  • None specified beyond approval durations; reauthorization may be granted per listed durations

Approval duration

3 to 12 months depending on indication